Roche Diabetes Care India has announced that their blood glucose monitoring device, the Accu-Chek Active, will now be manufactured in India as a part of the company’s commitment to improve access to diabetes care and meet the growing needs of the Indian market. The move is aimed at reducing the carbon footprint, creating employment opportunities, and strengthening Roche’s position as a leader in the blood glucose monitoring market in India. The first batch of Accu-Chek Active meters manufactured in India is already available on the market.
Roche Diabetes Care India has announced that its blood glucose monitoring device, the Accu-Chek Active, will now be manufactured in India as a part of the company’s strategy to improve access to diabetes care and meet the growing needs of the Indian market. The manufacturing process is being carried out in collaboration with the company’s manufacturing partner Sanmina-SCI India Pvt. Ltd., and assembly and distribution partner, Parekh Integrated Services Pvt. Ltd. (PISPL).
The production of Accu-Chek Active meters will take place in Sanmina’s state-of-the-art multi-client manufacturing site in Chennai, India, in line with globally approved quality standards synonymous with the brand. The new Accu-Chek Active product packs will now proudly display the ‘Made in India’ tag. The decision to manufacture these products in India is aimed at making Accu-Chek Active more accessible to the growing number of people with diabetes in the country, while also contributing to the global sustainability goals of reducing the carbon footprint versus imports.
The move is in line with Roche’s commitment to improving access to diabetes care by shortening their time to market and becoming more sustainable in their operations by reducing their carbon footprint. Roche Diabetes Care India offers integrated personalized diabetes management (iPDM) products and solutions through their Accu-Chek range of blood glucose monitoring systems, including Accu-Chek Active, Accu-Chek Guide, Accu-Chek Instant, and Accu-Chek Instant S, as well as tech-driven solutions on their mobile application, mySugr.
“We are delighted to announce the manufacturing of Accu-Chek Active meters in India in partnership with Sanmina.” For 125 years, sustainability has been an integral part of Roche’s business. This move is in line with our commitment to improving access to diabetes care by shortening our time to market and becoming more sustainable in our operations by reducing our carbon footprint. We are confident that this strategic decision will help us strengthen our position as a leader in the blood glucose monitoring market in India,” said Omar Sherief Mohammad, Cluster Head – India, Middle East, and Africa, RDC.
The first batch of Accu-Chek Active meters manufactured in India is already available on the market across the country. This move by Roche Diabetes Care India to manufacture Accu-Chek Active in India is expected to have a significant impact on the diabetes market in the country. The diabetes market in India is growing at a rapid pace, and it is estimated that by 2030, India will have the largest number of people with diabetes in the world. The availability of affordable and high-quality blood glucose monitoring devices is crucial to managing the disease and improving the quality of life for people living with diabetes.
Roche’s decision to manufacture Accu-Chek Active in India is also expected to create employment opportunities and boost the local economy. The manufacturing process will require skilled labor and the sourcing of raw materials and components from local suppliers, providing a significant boost to the local manufacturing ecosystem. It is a win-win situation for both Roche and India, as the company can improve access to diabetes care while supporting the country’s economic growth.
